A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...
Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...
Stem cell therapy uses stem cells or their derivatives to repair and regenerate tissues that have been diseased, damaged, or ...
With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...
Onlymyhealth on MSN
Abhay Deol reveals he got stem cell therapy – expert shares all about this treatment
When celebrities talk about a health condition or medical treatment, it garners attention. The same thing happened when ...
AZoLifeSciences on MSN
Cellares raises $257 million series D led by BlackRock and Eclipse to industrialize global cell therapy manufacturing with breakthrough automation
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D ...
Catalent made a series of deals early this decade to build up its presence in Gosselies. Now, it's planning to wind down cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results